Strategy Asset Managers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
3,008
-34
-1% -$12.1K 0.17% 93
2025
Q4
$996K Buy
3,042
+14
+0.5% +$4.44K 0.16% 92
2025
Q3
$854K Sell
3,028
-10
-0.3% -$2.9K 0.15% 104
2025
Q2
$848K Buy
3,038
+25
+0.8% +$7.08K 0.16% 103
2025
Q1
$939K Buy
3,013
+36
+1% +$10.6K 0.19% 86
2024
Q4
$776K Buy
2,977
+15
+0.5% +$4.45K 0.15% 106
2024
Q3
$954K Sell
2,962
-2,761
-48% -$903K 0.18% 92
2024
Q2
$1.27M Buy
5,723
+2,770
+94% +$814K 0.28% 67
2024
Q1
$840K Buy
2,953
+25
+0.9% +$7.32K 0.18% 90
2023
Q4
$843K Buy
2,928
+12
+0.4% +$3.27K 0.2% 81
2023
Q3
$784K Sell
2,916
-2,807
-49% -$701K 0.21% 83
2023
Q2
$1.27M Buy
5,723
+341
+6% +$79.1K 0.28% 67
2023
Q1
$1.3M Buy
5,382
+2,525
+88% +$620K 0.32% 63
2022
Q4
$750K Sell
2,857
-100
-3% -$26.8K 0.19% 96
2022
Q3
$667K Buy
2,957
+1,645
+125% +$399K 0.18% 104
2022
Q2
$319K Sell
1,312
-1,242
-49% -$304K 0.1% 134
2022
Q1
$617K Buy
2,554
+1,243
+95% +$286K 0.13% 133
2021
Q4
$295K Sell
1,311
-1,846
-58% -$390K 0.08% 146
2021
Q3
$671K Sell
3,157
-10
-0.3% -$2.3K 0.15% 130
2021
Q2
$772K Buy
3,167
+127
+4% +$31.2K 0.16% 104
2021
Q1
$756K Buy
3,040
+185
+6% +$44.1K 0.17% 101
2020
Q4
$656K Sell
2,855
-582
-17% -$134K 0.16% 111
2020
Q3
$874K Buy
3,437
+152
+5% +$37.7K 0.23% 82
2020
Q2
$775K Buy
3,285
+567
+21% +$129K 0.21% 82
2020
Q1
$551K Buy
2,718
+1,623
+148% +$355K 0.18% 96
2019
Q4
$264K Buy
+1,095
New +$241K 0.07% 176
2019
Q2
Sell
-160
Closed -$30K 122
2019
Q1
$30K Buy
+160
New +$30.6K 0.01% 166
2016
Q3
Sell
-13,583
Closed -$2.07M 127
2016
Q2
$2.07M Sell
13,583
-2,160
-14% -$336K 0.47% 75
2016
Q1
$2.36M Buy
+15,743
New +$2.34M 0.54% 68
2015
Q3
Sell
-16,525
Closed -$2.54M 135
2015
Q2
$2.54M Sell
16,525
-248
-1% -$39.7K 0.57% 61
2015
Q1
$2.68M Buy
+16,773
New +$2.64M 0.59% 59
2014
Q2
Sell
-24,451
Closed -$3.02M 131
2014
Q1
$3.02M Buy
+24,451
New +$2.97M 0.65% 48

Other funds holding AMGN

Strategy Asset Managers's AMGN Position: Q1 2026 in Review

Strategy Asset Managers reduced its Amgen (AMGN) stake by 1.1% in Q1 2026, selling an estimated $12.1K and leaving 3,008 shares worth $1.06M. The position accounts for 0.17% of the portfolio, ranked #93.

Strategy Asset Managers first reported a position in AMGN in Q1 2014 and has held it in 32 quarters since. The position peaked at $3.02M in Q1 2014. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Strategy Asset Managers held 3,008 shares of Amgen worth $1.06M as of Q1 2026.
  • Strategy Asset Managers sold 34 Amgen shares in Q1 2026, an estimated $12.1K.
  • Amgen made up 0.17% of Strategy Asset Managers's portfolio in Q1 2026, its #93 holding.
  • Strategy Asset Managers first reported a position in Amgen in Q1 2014 and has held it in 32 quarters since.
  • Strategy Asset Managers's Amgen position peaked at $3.02M in Q1 2014.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Strategy Asset Managers's 13F filing for Q1 2026, filed 12 May 2026.